Cerence Shares Gain Traction After Strong Quarter and Outlook

Cerence shares are trading higher after Goldman Sachs raised its price target to $11, following a solid quarter that surpassed revenue and EBITDA expectations, including a positive FY26 guidance. Craig-Hallum also acknowledged the improved balance sheet and cash flow, maintaining a Hold rating with a $10 price target.